Authors:
Singh, S
Mariappan, TT
Sankar, R
Sarda, N
Singh, B
Citation: S. Singh et al., A critical review of the probable reasons for the poor/variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem, INT J PHARM, 228(1-2), 2001, pp. 5-17